Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1967 1
1971 1
1972 4
1973 5
1974 2
1975 4
1977 1
1978 1
1979 5
1980 4
1981 2
1982 5
1983 6
1984 8
1985 10
1986 9
1987 7
1988 6
1989 8
1990 17
1991 13
1992 15
1993 16
1994 14
1995 19
1996 10
1997 7
1998 5
1999 8
2000 5
2001 5
2002 9
2003 9
2004 17
2005 19
2006 14
2007 10
2008 15
2009 11
2010 23
2011 15
2012 9
2013 20
2014 14
2015 15
2016 11
2017 18
2018 10
2019 19
2020 14
2021 23
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

503 results
Results by year
Filters applied: . Clear all
Page 1
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, Williams ME, Barrientos JC, Chmielowska E, Radford J, Stilgenbauer S, Dreyling M, Jedrzejczak WW, Johnson P, Spurgeon SE, Li L, Zhang L, Newberry K, Ou Z, Cheng N, Fang B, McGreivy J, Clow F, Buggy JJ, Chang BY, Beaupre DM, Kunkel LA, Blum KA. Wang ML, et al. Among authors: williams me. N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19. N Engl J Med. 2013. PMID: 23782157 Free PMC article. Clinical Trial.
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.
Wang ML, Blum KA, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, Williams ME, Barrientos JC, Chmielowska E, Radford J, Stilgenbauer S, Dreyling M, Jedrzejczak WW, Johnson P, Spurgeon SE, Zhang L, Baher L, Cheng M, Lee D, Beaupre DM, Rule S. Wang ML, et al. Among authors: williams me. Blood. 2015 Aug 6;126(6):739-45. doi: 10.1182/blood-2015-03-635326. Epub 2015 Jun 9. Blood. 2015. PMID: 26059948 Free PMC article. Clinical Trial.
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.
Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME, Abonour R, Siegel DS, Katz M, Greipp PR; Eastern Cooperative Oncology Group. Rajkumar SV, et al. Among authors: williams me. Lancet Oncol. 2010 Jan;11(1):29-37. doi: 10.1016/S1470-2045(09)70284-0. Epub 2009 Oct 21. Lancet Oncol. 2010. PMID: 19853510 Free PMC article. Clinical Trial.
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. McLaughlin P, et al. Among authors: williams me. J Clin Oncol. 1998 Aug;16(8):2825-33. doi: 10.1200/JCO.1998.16.8.2825. J Clin Oncol. 1998. PMID: 9704735 Clinical Trial.
Inorganic biomimetic nanostructures.
Levine LA, Williams ME. Levine LA, et al. Among authors: williams me. Curr Opin Chem Biol. 2009 Dec;13(5-6):669-77. doi: 10.1016/j.cbpa.2009.09.004. Epub 2009 Oct 7. Curr Opin Chem Biol. 2009. PMID: 19818676 Review.
Barriers to optimal ESKD management.
Williams ME. Williams ME. Semin Dial. 2020 Nov;33(6):437-439. doi: 10.1111/sdi.12941. Epub 2020 Nov 19. Semin Dial. 2020. PMID: 33210322 No abstract available.
Geriatric assessment.
Williams ME. Williams ME. Ann Intern Med. 1986 May;104(5):720-1. doi: 10.7326/0003-4819-104-5-720. Ann Intern Med. 1986. PMID: 3963668 No abstract available.
Internet organ solicitation, explained.
Williams ME. Williams ME. Adv Chronic Kidney Dis. 2006 Jan;13(1):70-5. doi: 10.1053/j.ackd.2005.10.003. Adv Chronic Kidney Dis. 2006. PMID: 16412973 Review.
503 results